2022
DOI: 10.1016/j.jlr.2022.100274
|View full text |Cite
|
Sign up to set email alerts
|

Blocking Lipid Uptake Pathways Does not Prevent Toxicity in Adipose Triglyceride Lipase (ATGL) Deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 53 publications
0
2
0
Order By: Relevance
“…Although humans also develop a cardiomyopathy with ATGL deficiency [62], the most dramatic symptoms in these patients are pain and weakness associated with skeletal muscle breakdown; circulating levels of the muscle enzyme creatine kinase are increased 10-fold [63 ▪ ]. A recent study attempted unsuccessfully to alleviate the cardiomyopathy due to ATGL deficiency by deletion of LPL or CD36 [64 ▪ ]. In agreement with these observations, ATGL-deficient cardiomyocytes develop LDs from de-novo fatty acid synthesis when grown in lipid-depleted media.…”
Section: Lipid Droplet Degradationmentioning
confidence: 99%
“…Although humans also develop a cardiomyopathy with ATGL deficiency [62], the most dramatic symptoms in these patients are pain and weakness associated with skeletal muscle breakdown; circulating levels of the muscle enzyme creatine kinase are increased 10-fold [63 ▪ ]. A recent study attempted unsuccessfully to alleviate the cardiomyopathy due to ATGL deficiency by deletion of LPL or CD36 [64 ▪ ]. In agreement with these observations, ATGL-deficient cardiomyocytes develop LDs from de-novo fatty acid synthesis when grown in lipid-depleted media.…”
Section: Lipid Droplet Degradationmentioning
confidence: 99%
“…A family of proteins named perilipin (PLINs) is involved in lipid uptake, coating, and addressing LDs inside cells (Frank et al, 2015;Najt et al, 2022). Perilipin 1 was the first perilipin described (Greenberg et al, 1991) and after its discovery, the study of LDs, their lipidomic and proteomics, and the role of LDs in health and disease have increased dramatically, expanding the LD biology field (Kobayashi et al, 2008;Kuerschner et al, 2008;Garcıá-Arcos et al, 2010;Turchetto-Zolet et al, 2011;Hsieh et al, 2012;Lin et al, 2014;Markgraf et al, 2014;Kamili et al, 2015;Li et al, 2015;Viktorova et al, 2018;Freyre et al, 2019;Guyard et al, 2022;Kim et al, 2022;Oluwadare et al, 2022).…”
Section: Lipid Metabolismmentioning
confidence: 99%